Health Canada — Medical Devices · Canada · 2020-03-13 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Accriva Diagnostics has identified that some Hemochron Signature Elite Analyzers may not maintain a temperature of 37°C ±1.0°C degrees in some operating environments as outlined in the operators manual (P/N HX1101). Software version 2.4 has been developed to ensure that the Hemochron Signature Elite maintains a temperature of 37°C ±1.0°C throughout the duration of the assay.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.